-
Transvaginal ultrasound in pregnancy: its acceptability to women and maternal psychological morbidity.
Clement S, Candy B, Heath V, To M, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;22:508-14. -
Sonographic markers of fetal aneuploidy: a review.
Cicero S, Sacchini C, Rembouskos G, Nicolaides KH.
Placenta 2003;24:S88-98. -
Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH.
Prenat Diagn 2003;23:306-10. -
Absent nasal bone at 11-14 weeks of gestation and chromosomal defects.
Cicero S, Longo D, Rembouskos G, Sacchini C, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;22:31-5. -
Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks.
Cicero S, Dezerega V, Andrade E, Scheier M, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;22:135-7. -
Nasal bone hypoplasia in trisomy 21 at 15-22 weeks' gestation.
Cicero S, Sonek JD, McKenna DS, Croom CS, Johnson L, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;21:15-8. -
First-trimester maternal serum PAPP-A, SP1 and M-CSF levels in normal and trisomic twin pregnancies.
Bersinger NA, Noble P, Nicolaides KH.
Prenat Diagn 2003;23:157-62. -
Distribution of fetal erythroblasts enriched from maternal blood in multifetal pregnancies.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
Hum Reprod 2003;18:1933-6. -
Fetal erythroblasts in maternal blood in relation to gestational age.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
J Matern Fetal Neonatal Med 2003;14:392-7. -
Distribution of fetal erythroblasts in maternal blood after chorionic villous sampling.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
BJOG 2003;110:33-8. -
The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.
Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J, Stark GB, Alitalo K, Tomarev SI, Niemeyer C, Rossler J.
FASEB J 2002;16:1271-3. -
Cervical screening for preterm delivery.
Welsh A, Nicolaides K.
Curr Opin Obstet Gynecol 2002;14:195-202. -
Elective cerclage vs ultrasound-indicated cerclage in high-risk pregnancies.
To MS, Palaniappan V, Skentou C, Gibb D, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;19:475-7. -
A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A.
Spencer K, Nicolaides KH.
Prenat Diagn 2002;22:877-9. -
Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome.
Sonek JD, Nicolaides KH.
Am J Obstet Gynecol 2002;186:139-41. -
Increased fetal nuchal translucency at 11-14 weeks.
Nicolaides KH, Heath V, Cicero S.
Prenat Diagn 2002;22:308-15. -
One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation.
Nicolaides KH, Bindra R, Heath V, Cicero S.
J Matern Fetal Neonatal Med 2002;12:9-18. -
Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11-14 weeks of gestation.
Cicero S, Bindra R, Rembouskos G, Tripsanas C, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;11:400-2. -
Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 weeks.
Bindra R, Heath V, Nicolaides KH.
Clin Obstet Gynecol 2002;45:661-70. -
One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies.
Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:219-25.